|
SEARCH | SUBSCRIBE | ||
|
What's
Left for Canadians If Americans Buy Their Drugs? By
Tasmin Carlisle, The Wall Street Journal A Canadian
pharmacists' group is blaming the burgeoning trade in prescription-drug
sales to Barry
Power, a director of the Canadian Pharmacists Association, says his
organization has been hearing from members across the country that supply
problems are cropping up more often and lasting longer than before the
Internet pharmacies set up shop. While
Canada's federal health ministry says it doesn't have any evidence that
the online pharmacies are causing shortages, a senior official
acknowledged last week that swelling cross-border sales raise that risk. In a letter
to provincial regulators, pharmacy associations and medical groups, Health
Canada Assistant Deputy Minister Diane Gorman said the federal agency
"regards this as a very serious matter." The letter requested
any "information regarding early indications of drug-supply
problems" or "trends regarding drug supply, safety concerns or
impacts on human resources which may pose risks to Canadians'
health." The
Canadian International Pharmacy Association, which represents Canadian
pharmacies offering Several big
pharmaceutical companies, including Pfizer
Inc. and GlaxoSmithKline
PLC, have said they would limit sales of patent-protected prescription
drugs to Canada over concerns that Canadian Internet pharmacies are
re-exporting the drugs to the U.S. One of the latest companies to do so is
Eli
Lilly & Co., Indianapolis, which started limiting drug sales to
Canadian pharmacies last week. The prairie Michele Fontaine, vice
president of the Coalition for Manitoba Pharmacy -- a group of traditional
pharmacists opposed to the Internet drugstores -- says she recently has
had difficulty obtaining enough of two cancer drugs and a blood-pressure
drug to fill prescriptions for her customers at a chainstore outlet in "We are almost panicked by
the thought of having to tell a parent of a child with leukemia that we
couldn't get the drug," Ms. Fontaine said. A spokesman for Teva said that
there shouldn't be shortages of the drug, although there previously had
been a manufacturing hitch with the product. Ms. Fontaine said other
medications in short supply in the sparsely populated province include
Temodal, used to treat brain tumors, and 240 milligram-dose Chronovera, a
blood-pressure medication. Temodal is made by Schering-Plough
Corp., of Kenilworth, N.J., and Chronovera by New York-based Pfizer. Ms. Fontaine say shortages of
particular drugs occur from time to time in Don Sancton, a spokesman for
Pfizer's Canadian unit, said Chronovera 240 mg has been in short supply
"for some months" due to a manufacturing problem in Canada that
is expected to last "a couple of months longer." He said he was
surprised to hear that the product is available from some Internet
pharmacies. Schering-Plough didn't return
calls seeking comment. Due to federal regulation of
drug pricing in Several financially strapped In a research report,
Prudential Financial analysts Diane Duston and Tim M. Anderson say that
Canadian government data show a rise in Canadian pharmaceutical imports
from offshore sources such as Copyright
© 2002 Global Action on Aging |